All News

Study shows the mortality rate among breast cancer survivors is lower among those who received fertility preservation.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

The papers in the special issue highlight the research team’s focus on understanding the experiences of caregivers of persons with TBI and illustrate the team’s ability to efficiently capture those experiences through a tool known as TBI-CareQOL Measurement System.

Individuals who reported zero or fewer live births and those who reported many live births had markers of quicker aging than those who reported 3 or 4 births.

The cost of oncology treatment is high and rising in the United States.

Distribution of the first 2.9 million doses of the COVID--19 vaccine jointly developed by Pfizer and BioNTech are expected to begin within hours of the FDA’s decision.

A member of the FDA’s expert advisory committee who voted in favor of Pfizer and BioNTech’s COVID-19 vaccine said that distribution of the first vaccines to high priority populations in the United States could begin as early as Monday.

Genetic predisposition is only part of the pre-eclampsia risk.

Medication nonadherence results in greater health care spending and poorer patient health outcomes.

Supreme Court decision establishes that states do have the right to regulate pharmacy benefit managers in managed care organizations.

Direct-to-consumer COVID-19 kit allows for anyone over 18 years of age to perform a nasal swab on themselves and send the sample off for testing.

Variability in prescrption handoffs might make the difference between a patient who is adherent or not.

An icatibant injection has been released in the United States as an alternative treatment for acute attacks of hereditary angioedema in adults over the age of 18 years.

Cinacalcet Tablets are used to treat hyperparathyroidism (overactive functioning of the parathyroid glands) in people who are on long-term dialysis for kidney disease.

Younger and Black patients are more likely to experience breast cancer symptom under-recognition.

If current drug pricing trends continue, cost-related non-adherence to therapy will result in the premature deaths of 112,000 Medicare beneficiaries per year.

A new combination therapy cleanses the colon before this important procedure that screens for colorectal cancer, the third-leading cause of cancer-related deaths in the United States.

The tau protein can help identify Alzheimer disease before cognitive decline begins.

The FDA-approved generic is therapeutically equivalent to Mallinckrodt Pharmaceuticals’ acetaminophen injection product (Ofirmev).

Accurate blood pressure measurement is crucial to diagnose hypertension and guide treatment.

Female patients being treated for heart attack also tend to be older and have more complicated medical histories.

The objective of the study was to quantify glucocorticoid dose-dependent cardiovascular risk in people with 6 immune-mediated inflammatory diseases.

Delirium was the sixth most common presenting symptom in all patients, suggesting the clinical importance of including delirium on checklists of presenting signs and symptoms for COVID-19.

Drospirenone and Ethinyl Estradiol Tablets are a combination birth control pill containing female hormones that prevent ovulation.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week

New research identifies patients most at risk of continuing problems with medulloblastoma, which can be applied immediately in medical clinics.

A flu vaccine is especially important this year, as it can prevent a “twindemic” with COVID-19.

A recent nationwide survey of 400 pharmacists conducted by the American Pharmacists Association (APhA) found that more than three-fourths of pharmacists plan to be vaccinated with 1 of the coronavirus disease 2019 (COVID-19) vaccines.